Tips For Tradespeople Working in the Cold Weather
Reading Time: 4 minutes Work doesn’t stop when the weather gets cold. But at this time of year, it’s more important than ever to understand how to keep yourself safe and what steps to take when working in cold winter conditions. From your clothing
Expert Shares the Top Energy Saving Tips for 2025
Reading Time: 5 minutes Energy costs are consistently on the rise, and most of us are looking desperately for ways to cut back our bills in the new year. Here are some top tips from energy expert William Hobbs at MyJobQuote.co.uk on
PopVax is Awarded 2 Million USD as One of the Winners of the BARDA Patch Forward Prize for its Seasonal Influenza Vaccine built on a Novel mRNA-encoded Immunogen Display Architecture Delivered via Dissolvable Microarray Patch
Reading Time: 3 minutes PopVax, an Indian full-stack biotechnology company developing broadly-protective mRNA vaccines using machine learning-enabled computational protein design, is delighted to announce that it has been awarded $2 million by the United States Biomedical Advanced Research and Development Authority (BARDA) as one of the winners of the Concept
Proposal of HKFoods Plc’s Shareholders’ Nomination Board to the following Annual General Meeting
Reading Time: 3 minutes HKFoods Plc, Stock Exchange Release 13 January 2025, at 5.45 pm EET The Shareholders’ Nomination Board of HKFoods Plc has prepared proposals on the composition and the remuneration of the Board of Directors to the HKFoods’ 2025 Annual General Meeting. Number
Arctic Bioscience – funded to cash positive
Reading Time: 2 minutes Arctic Bioscience is now funded through a NOK 30 million loan facility. Strong 30% y/y growth in sales revenues in 2024 and prospects of continued strong growth in coming years. Psoriasis drug candidate HRO350 on track for 12 months readout end of
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 13.01.2025
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 13.01.2025 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 13.01.2025 Date 13.01.2025 Exchange transaction Buy Share class ALEX Amount 200 Average price/share 8,8500 EUR Highest
OncoZenge AB has entered into a non-binding agreement with the intention to partner with Molteni Farmaceutici for commercialization of BupiZenge™ in Europe
Reading Time: 3 minutes STOCKHOLM, SWEDEN – January 13, 2025 – OncoZenge AB (publ) (“OncoZenge” or the “Company”), announces that the Company has entered into a non-binding agreement with the intention to partner with pharmaceutical leader Molteni Farmaceutici (“Molteni”) regarding exclusive rights to commercialization of BupiZenge™
Nordea Bank Abp: Repurchase of own shares on 13.01.2025
Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares13.01.2025 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 13.01.2025 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average
Tele2 announces changes to the Group Leadership Team
Reading Time: 2 minutes Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) announces that Kim Hagberg, Executive Vice President, Chief Operations, will leave her position effective from today. Kim joined Tele2 in 2013 and has held many positions over the
Roc Oil Company Pty Limited announces the final outcome of the recommended cash offer to the shareholders of Tethys Oil AB
Reading Time: 10 minutes THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA OR SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT